People · Operator
Named in public records as an officer, director or promoter · active 2016–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Panome Bio Inc. | — | Biotechnology | Series A | $12.0M | $26.3M | 2023 |
| Canopy Biosciences, LLC | — | Biotechnology | Seed | $3.2M | $92.1M | 2016 |
| Inflection Point Genetics Inc. | — | Biotechnology | Pre-Seed | $265K | $3.5M | 2022 |
Edward Weinstein at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Edward Weinstein on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Smoller | 2 | 6 |
| Charles Bolten | 1 | 10 |
| DEVAL LASHKARI | 1 | 6 |
| Alexander Herzick | 1 | 3 |
| David Kingsley | 1 | 2 |
| Crystal Winkeler | 1 | 2 |
| Tom Cohen | 1 | 2 |
| Rob Capone | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.